GeneOne Life Science, Inc.

A011000

KR7011000007

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
2,260 ^KRW	-0.88%		-3.42%	-20.42%

05-16	GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	CI

GeneOne Life Science, Inc.(KOSE:A011000) added to S&P Global BMI Index

September 21, 2020 at 05:00 am

Latest news about GeneOne Life Science, Inc.

GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	03-27	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
GeneOne Life Science, Inc. announced that it expects to receive KRW 3.6000014 billion in funding	03-20	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
GeneOne Life Science, Inc. announced that it has received KRW 2.46998556 billion in funding	14/09/23	CI
Gene One Life Science to Raise 2.5 Billion Won via Stock Sale	07/09/23	MT
GeneOne Life Science, Inc. announced that it expects to receive KRW 2.46998556 billion in funding	05/09/23	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Gene One Life Science to Raise 80 Billion Won via Share Sale	17/05/23	MT
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22	CI
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
GeneOne Life Science, Inc. announced that it has received KRW 11.7 billion in funding	14/04/22	CI
GeneOne Life Science, Inc. announced that it expects to receive KRW 11.7 billion in funding	12/04/22	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	08/11/21	CI
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June	12/04/21	RE
GeneOne Life Science, Inc. announced that it has received KRW 24 billion in funding from a group of investors	24/11/20	CI
GeneOne Life Science, Inc. announced that it expects to receive KRW 24 billion in funding from a group of investors	22/11/20	CI
VGX Pharmaceuticals, Inc. Terminates CELLECTRA Device License Agreement with GeneOne	15/10/20	CI
GeneOne Life Science, Inc.(KOSE:A011000) added to S&P Global BMI Index	21/09/20	CI
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data with DNA Vaccine INO-4700 for MERS Coronavirus a the American Society of Gene & Cell Therapy Conference	28/04/20	CI
GeneOne Life Science, Inc.(KOSE:A011000) dropped from S&P Global BMI Index	23/09/19	CI
GeneOne Life Science, Inc. announced that it has received KRW 2.95000061 billion in funding	07/07/19	CI

Chart GeneOne Life Science, Inc.

Duration

Period

More charts

GeneOneLifeScience, formerly VGX International, Inc., is a Korea-based company engaged in textile and biopharmaceutical businesses. The Company is a biomedical contract manufacturing organization (CMO). Its textile business engages in the provision of wicks under the brand name of INTERON, which are used in dress shirts, suits and caps. Its biopharmaceutical business engages in the research, development and manufacture of biomedical, plasmid deoxyribonucleic acid (DNA) and DNA vaccines. It also engaged in the leasing of nonresidential buildings.

Sector

Biotechnology & Medical Research

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENEONE LIFE SCIENCE, INC.	-20.42%	134M
MODERNA, INC.	+54.05%	63.85B
IQVIA HOLDINGS INC.	-2.02%	41.83B
LONZA GROUP AG	+40.01%	40.47B
CELLTRION, INC.	-10.22%	27.17B
ICON PUBLIC LIMITED COMPANY	+13.42%	26.52B
ALNYLAM PHARMACEUTICALS, INC.	-21.60%	18.69B
BIO-TECHNE CORPORATION	+2.89%	12.73B
UNITED THERAPEUTICS CORPORATION	+22.40%	12.11B
MEDPACE HOLDINGS, INC.	+27.49%	12.07B